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Hydrogel cross-linking–programmed release of nitric 
oxide regulates source-dependent angiogenic 
behaviors of human mesenchymal stem cell
Mi-Lan Kang1,2*, Hye-Seon Kim1*, Jin You1*, Young Sik Choi3, Byeong-Ju Kwon1,  
Chan Hee Park4, Wooyeol Baek5, Min Sup Kim1, Yong Jae Lee3, Gun-Il Im6, Jeong-Kee Yoon1,  
Jung Bok Lee1, Hak-Joon Sung1†
Angiogenesis is stimulated by nitric oxide (NO) production in endothelial cells (ECs). Although proangiogenic 
actions of human mesenchymal stem cells (hMSCs) have been extensively studied, the mechanistic role of NO in this 
action remains obscure. Here, we used a gelatin hydrogel that releases NO upon crosslinking by a transglutaminase 
reaction (“NO gel”). Then, the source-specific behaviors of bone marrow versus adipose tissue-derived hMSCs 
(BMSCs versus ADSCs) were monitored in the NO gels. NO inhibition resulted in significant decreases in their 
angiogenic activities. The NO gel induced pericyte-like characteristics in BMSCs in contrast to EC differentiation in 
ADSCs, as evidenced by tube stabilization versus tube formation, 3D colocalization versus 2D coformation with EC 
tube networks, pericyte-like wound healing versus EC-like vasculogenesis in gel plugs, and pericyte versus EC 
marker production. These results provide previously unidentified insights into the effects of NO in regulating 
hMSC source-specific angiogenic mechanisms and their therapeutic applications. 
INTRODUCTION
Nitric oxide (NO) is a potent proangiogenic stimulator upon pro-
duction by endothelial cells (ECs) (1) and can be generated using 
ammonia (NH3) (2). NO is a vasodilator and promotes EC growth 
and migration, thereby promoting new vessel sprouting from existing 
ones. Hence, various NO-releasing biomaterials have recently been 
used to study the beneficial effects of NO on tissue regeneration (3). 
This particular function was programmed to promote vascular 
regeneration and therapy in the form of surface coating, nanoparticles, 
hydrogel, and scaffolds. However, the temporal release settings hamper 
their long-term applications (4), indicating a significant need to use 
a material template that is programmed to release NO continuously. 
For example, an essential NO source is deposited into a template so 
that NO can be released by further reaction or biosynthesis over a 
long period.
Significant advances have been made to regenerate tissues using 
human mesenchymal stem cells (hMSCs), leading to clinical trials 
for a range of therapeutic applications. Despite their promise, hMSC 
transplantation requires in vitro expansion to achieve the relevant 
number of cells, and serially expanded hMSCs demonstrate cell aging–
associated changes in their therapeutic potential (5). Hence, this 
progressive alteration in donor cell properties should be thoroughly 
investigated to improve their successful clinical uses. Moreover, their 
therapeutic potential and mechanism of action vary depending on 
their tissue of origin (6). hMSCs can be isolated from fetal and most adult 
tissues. Bone marrow–derived MSCs (BMSCs) were discovered first 
and have been widely used for clinical applications. Adipose tissue–
derived MSCs (ADSCs) can be more easily isolated in larger amounts. 
These two types of hMSCs have been most widely studied because 
of their many shared biological properties, therapeutic efficiencies, 
and safe applications. However, growing evidence suggests that 
BMSCs and ADSCs have different immunophenotypes, differentiation 
potentials, and transcriptome, proteome, and immunomodulatory 
activities (7).
The therapeutic potential of MSCs is predominantly a result of 
their proangiogenic activities (8). While efforts have been made 
recently to elucidate other aspects of the difference between BMSCs 
and ADSCs (7), their different proangiogenic behaviors have not 
been thoroughly investigated yet. The main proangiogenic mecha-
nisms of hMSCs include paracrine effects (8), endothelial differen-
tiation (9), and pericyte function (10). Regardless of the hMSC type, 
a consensus has been reached on the paracrine mechanism because 
most hMSCs are known to release proangiogenic factors (11). However, 
hMSC type–dependent endothelial differentiation and pericyte func-
tions remain unclear. hMSCs not only transdifferentiate into ECs (9) 
but also exhibit inherent similarities with pericytes (12), a supportive 
cell type that localizes on abluminal sites on an EC layer and regu-
lates vascular stabilization, remodeling, and homeostasis. Previous 
studies have reported that the proangiogenic activity of ADSCs is 
driven partly by their endothelial differentiation and is higher 
than that of BMSCs in a mouse model of hindlimb ischemia (13). 
Because NO generation was found to enhance proangiogenic potential 
(3) and endothelial differentiation (14) of MSCs, the regulatory 
role of NO may differentiate these angiogenic actions between 
BMSCs and ADSCs.
In this study, gelatin cross-linking by microbial transglutaminase 
(mTG) resulted in deposition of ammonia (NH3) and the consequent 
release of NO via a further biosynthetic reaction for a long period 
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(“NO gel”). We compared the proangiogenic effects of NO on EC 
differentiation and pericyte function of ADSCs versus BMSCs in 
NO gels with stiffness optimized to 1.5 kPa (elastic modulus). The 
NO gel induced pericyte actions in BMSCs, as evidenced by enhanced 
tube stabilization, close-contact localization with ECs inside the gel 
matrix, enhanced pericyte-like wound healing in animal models, 
and expression of well-known pericyte markers. In contrast, the NO 
gel promoted predominantly EC-like characteristics of ADSCs, as 
evidenced by tube formation, two-dimensional (2D) coformation 
with an EC network, endothelial differentiation–mediated vasculo-
genesis in a gel plug assay, and increased expression of the main EC 
markers. This study suggests that the effect of NO should be considered 
to select the hMSC type depending on the purpose of hMSC therapy 
owing to its regulatory role in hMSC source–dependent angiogenic 
mechanisms.
RESULTS
NO gel preparation
During gelatin cross-linking, mTG catalyzed isopeptide bond forma-
tion of -carboxamide groups [-(C═O)NH2] of glutamine with 
-amino groups (-NH3) of lysine, resulting in NH3 deposition in 
gelatin. This setting was programmed to continuously release NO 
as result of partial oxidation of NH3 through the biosynthetic coupling 
of the NO cycle with other cycles (e.g., urea cycle) (2). In addition to 
NO release, this NO gel was used because of the ease of placing cells 
into the gel and the ability to monitor hMSC behavior in the 3D 
environment within the gel compared with that on the 2D surface 
on the gel under coculture and implantation conditions. Gel stiffness 
was varied by controlling the cross-linking degree [NO gels (cross-
linker weight/total solution volume%): 2.4% (#1), 4.8% (#2), and 9.6% 
(#3)], and the corresponding elastic modulus was determined using 
a rheometer. The modulus increased after gelation for 24 hours 
(table S1) as the mTG concentration was increased (Fig. 1A) from 
NO 2.4% gel (#1: ~1.5 kPa) to 4.8% (#2: ~2.3 kPa) and further to 
9.6% (#3: ~3.4 kPa).
As an indication of NO source deposition to the gels, the ammonia 
(NH3) concentration increased proportionally to the used mTG 
amount but inversely proportionally to the gel stiffness, with the 
highest ammonia concentration in NO 9.6% gel (#3:~3.4 kPa) 
(Fig. 1B-i), enabling the gels to set the NO release by partial ammonia 
oxidation in the gel system and further to control the deposition of 
the amount of NH3. Because ammonia can also be produced through 
the mTG reaction with intracellular polyamine substrates, the poly-
amine concentration in hMSCs after NO gel culture increased in an 
inversely proportional manner to the used mTG amount (Fig. 1B-ii), 
which serves as another evidence of NO release in the gel upon 
hMSC culture. hMSCs were defined by marker expression following 
the minimal criteria of defining MSCs by the International Society 
of Cellular Therapy (fig. S1) (15). All hMSCs fully expressed the posi-
tive markers (>99%) but barely expressed the negative markers (<1%).
ADSCs and BMSCs cultured in NO gels of 2.4% (#1) supported 
in vitro 3D growth and sprouting of both hMSC types better than 
NO gels of 4.8% (#2) and 9.6% (#3) over 7 days (Fig. 1C), which was 
confirmed by most microvessel outgrowth with the highest sprouting 
area values in the ex vivo culture of rat aortic rings in test gels 
(Fig. 1D). To equalize the concentration of NO among the three test 
gels but to vary the stiffness, NO gels of 2.4% (#1) and 4.8% (#2) 
were supplemented with ammonia to reach the level equal to 9.6% 
(#3). Then, the incremental multiples of vascular sprouting area from 
7 to 10 days were determined. Although the ammonia amount was 
equalized, more vessels sprouted in the 2.4% (#1) gel compared 
with those in the other gels. Only the 2.4% (#1) gel exhibited pro-
motion of vessel sprouting by ammonia supplementation (Fig. 1D). 
These results suggest that gel stiffness plays a key role in regulating 
hMSC behavior such as sprouting outgrowth in addition to the 
proangiogenic NO effect, with the NO gel 2.4% (#1: ~1.5 kPa) being 
the most supportive among the test groups. This was used for the 
following analyses.
Monoculture of hMSC in NO gel
Proangiogenic behaviors of ADSCs and BMSCs at passage 3 (P3) 
and P6 in the NO gel 2.4% (#1: ~1.5 kPa) were compared after 
14 days of culture. While both passages of ADSCs exhibited robust 
cell-cell interactions with tube formation, such morphology was 
much less observed in both passages of BMSCs (Fig. 2A-i). Pro-
angiogenic genes, platelet EC adhesion molecule 1 (PECAM1) and 
fetal liver kinase 1 (Flk1), were significantly up-regulated in the gel 
culture of ADSCs after both passages compared with 2D culture on 
tissue culture polystyrene (TCPS) (Fig. 2A-ii). However, only P6 of 
BMSCs in the gel expressed CD34, PECAM1, Flk1, and vascular 
endothelial cadherin (VE-cadherin) genes at significantly higher 
levels than TCPS in contrast to P3 cells (Fig. 2A-ii). The overall gene 
expression increased from P3 to P6 in both hMSC types. This result 
agrees well with the results of a previous study, in which NO promoted 
ex vivo angiogenesis of aged cells and in vivo wound repair in an 
aged mouse model (16). Therefore, P6 cells were used for sub-
sequent analyses.
The effect of the presence versus absence of hMSCs on the NO 
release of the #1 gel was compared by profiling the cumulative NO 
amount for 14 days (fig. S2A). Under both conditions, NO was con-
tinuously released for the initial 5 days with the sharper slopes in the 
presence of ADSCs or BMSCs compared with that in the absence of 
hMSCs (NO gel only). This difference became much clearer after 
day 5, when a minimal increase in the NO gel was noted compared 
with the continuously significant increase in the presence of hMSCs 
until day 14. The results confirm a causative role of hMSC presence 
in maintaining sustained NO release (“programmed release”). Gene 
expression of stemness markers, Kruppel-like factor 4 (Klf4) and 
CD271, increased visibly in the NO gel culture of ADSCs in both 
passages compared with culture in TCPS, whereas there was no visible 
difference between the NO gel and TCPS culture of BMSCs in both 
passages (fig. S2B). These results indicate that ADSCs are more sus-
ceptible to the effect of NO gel culture than BMSCs. Gene expression 
of EC markers, PECAM1 and Flk1, was significantly higher in P6 of 
the ADSC culture compared with that in P6 of the BMSC culture, 
whereas only Flk1 expression was significantly higher in P3 of ADSCs 
compared with P3 of BMSCs (fig. S2C). Protein expressions of EC 
markers, PECAM1 and Flk1, were clearly higher in ADSCs compared 
with that in BMSCs (Fig. 2B-i), which was confirmed by Western 
blotting (Fig. 2B-ii) and supported by enzyme-linked immuno-
sorbent assay (ELISA)–based determination of the cumulative release 
of VE growth factor (VEGF) (fig. S2D). ADSCs also exhibited sig-
nificantly higher amounts of low-density lipoprotein (LDL) uptake 
compared with BMSCs on day 14 after culture in the NO gel 
(Fig. 2B-vi). Meanwhile, the cumulative secretion of angiopoietin 1 
(ANGPT1), a pericyte-mediated vessel-stabilizing factor, was main-
tained at higher levels in BMSCs than in ADSCs in the NO gel culture 
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(Fig. 2B-iii). These series of results suggest that the NO gel sup-
ports a more predominant potential for ADSCs to differentiate 
into EC-like cells compared with the pericyte-like characteristics of 
BMSCs.
To determine whether NO production was induced both intra-
cellularly and environmentally by the NO gel system, intracellular 
NO levels of hMSCs and external NO levels in the culture medium 
were measured. Because NO can be oxidized to nitrite (NO2−) and 
nitrate (NO3−), the concentrations of these anion (“total NO con-
centration”) were measured as a proof of NO production. The 3D 
NO gel culture of hMSCs for 14 days exhibited a significantly high-
er total NO concentration compared with the 2D TCPS culture for 
14 days (Fig. 2C). Aminoguanidine (AG) inhibited all the inducible, 
endothelial, and neuronal NO synthase (NOS) (17). The immuno-
staining images showed that AG treatment significantly reduced 
tube formation in both hMSC types (Fig. 2D-i), which was supported 
by the quantitative analysis of angiogenic parameters (Fig. 2D-ii). 
NO production in the NO gel was confirmed by culturing human 
umbilical vein ECs (HUVECs), followed by Gene Ontology analysis 
of microarray data (Fig. 2D-iii). The 3D NO gel culture exhibited 
significantly higher expression levels of NO biosynthetic process–
related genes compared with the 2D TCPS culture (Fig. 2D-iii). After 
NO inhibition by AG treatment, genes were markedly down-regulated 
in BMSCs after NO gel culture, while no significant differences 
were noted in ADSCs (Fig. 2D-iii). These results suggest that 
BMSCs were more susceptible to NO inhibition compared with 
ADSCs, although tube formation of both hMSC types was attenuated 
similarly by NO inhibition, indicating the support of another 
mechanism rather than NO inhibition for the angiogenic behavior 
of ADSCs.
Fig. 1. Characterization of NO gel. (A) Elastic modulus of NO gel prepared with different ratios of gelatin and mTG [NO gels (cross-linker weight/total solution volume %): 
2.4% (#1), 4.8% (#2), and 9.6% (#3)]. Rheometer measurement of storage modulus (G′) and loss modulus (G″) of each NO gel formulation immediately after and 24 hours 
after gelation. (B) (i) Ammonia concentration of NO gels [2.4% (#1), 4.8% (#2), and 9.6% (#3)] (n = 3). (ii) Intracellular polyamine concentration of ADSC (n = 2, triplicates) 
in NO gels (#1 to #3) after 5-day culture. All data are presented as means ± SD. *P < 0.05 and **P < 0.01. (C) Behaviors of the two hMSC types in NO gels [2.4% (#1), 4.8% 
(#2), and 9.6% (#3)] after 7-day culture with live (green)/dead (red) staining. DAPI, 4′,6-diamidino-2-phenylindole. (D) Microvessel sprouting from ex vivo culture with rat 
aortic ring (n = 10) in NO gels 2.4% (#1), 4.8% (#2), and 9.6% (#3) with a quantitative analysis of sprouting area. (i) NO 2.4% (#1) and 4.8% (#2) gels were supplemented with 
ammonia to reach the level equal to 9.6% (#3). (ii) Then, the incremental multiples of vascular sprouting area from 7 to 10 days were determined and presented as a ratio 
with the value corresponding to NO gel 9.6% (#3) set to 1. *P < 0.05, **P < 0.01, and ***P < 0.001 between the groups where the ammonia concentration was the same 
but the stiffness was different. #P < 0.05 between the groups where the stiffness was the same and the ammonia concentration was different. $$P < 0.01 between the 
groups where both stiffness and ammonia concentration were different. ns, not significantly different. All data are presented as means ± SD (photo credit: Hye-Seon Kim, 
Yonsei University College of Medicine). 
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Coculture of MSCs and ECs in the NO gel
The differences of the NO-guided angiogenic mechanism became 
more apparent in coculture with HUVECs within NO gels for 14 days. 
After hMSCs were placed inside NO gels, HUVECs were seeded as 
a monolayer onto the gel surface after gelation (Fig. 3A). HUVECs 
seeded without hMSCs were used as the control (i.e., HUVEC 
monoculture). This coculture system allowed us to analyze paracrine 
action, colocalization, and differentiation of hMSCs in close contact 
with red fluorescent protein (RFP)–expressing HUVECs. Upon 
coculturing at day 1, HUVECs initiated clustering over the surface 
in all the three conditions. These HUVEC clusters showed more 
sprouting in the ADSC coculture compared with the other groups 
at day 7. However, only the BMSC coculture demonstrated con-
tinuous increases in sprouting with stable structures compared with 
the other groups at day 14. These results agree well with the above 
results in that the NO gel promotes the pericyte role of BMSCs in 
stabilizing vascular networks over 14 days, whereas ADSCs act like 
ECs in the NO gel in the initial 7 days of coculture. These results are 
Fig. 2. Evidence of EC-like ADSC and pericyte-like BMSC behavior at P3 and P6 in 14-day in vitro NO gel culture. (A) (i) Comparison of morphology with live (green)/
dead (red) staining. Red arrows indicate tubular formation through cell lining. (ii) Expression of angiogenesis genes, CD34, PECAM1, Flk1, and VE-cadherin by reverse 
transcription polymerase chain reaction (RT-PCR) and real-time quantitative PCR (qPCR) in hMSCs (n = 4) after NO gel culture (fold change to their corresponding mono-
layer culture on TCPS). P3, passage 3; P6, passage 6. (B) (i) Immunostaining and (ii) Western blotting analysis of PECAM1 and Flk1 proteins in hMSCs (n = 3) after NO gel 
culture. In immunostaining, phalloidin staining shows actin organization. In Western blotting, the common housekeeping gene -tubulin was used for normalization of 
expression. (iii) Angiopoietin 1 (ANGPT1) secretion from hMSCs (n = 3) after NO gel culture by enzyme-linked immunosorbent assay (ELISA). (iv) Quantitative determina-
tion of low-density lipoprotein (LDL) uptake by hMSCs (n = 2) after treatment with LDL for 1 day on day 14 after culture in NO gel. (C) NO concentration of hMSCs (n = 3) 
on days 5 (short term) and 14 (long term) after NO gel culture. Total NO concentration represents nitrite and nitrate. (D) (i) Immunostaining of NOS of hMSCs after NO gel 
culture after treatment with the NO inhibitor, aminoguanidine (AG). (ii) Quantitative analysis of tube formation by hMSCs (n = 3) after NO gel culture on day 5 after AG 
treatment (1 mM). Data are presented as % to n/t (nontreatment) of each angiogenic parameter (i.e., node, junction, segment, branch, length, and branching length). 
(iii) Left: Expression levels of NO biosynthesis–related genes, interleukin-6 (IL-6), clusterin (CLU), prostaglandin-I synthase (PTGIS), pentraxin-related protein 3 (PTX3), and 
intercellular adhesion molecule 1 (ICAM1), in monoculture of human umbilical vein ECs (HUVECs) only after 3D NO gel culture (3DH) versus their 2D monolayer culture 
(2DH) by microarray analysis. Right: Expression levels of the genes in monoculture of hMSCs only (n = 3) after NO gel culture on day 14 after AG treatment by RT-PCR. All 
data are presented as means ± SD. *P < 0.05, **P < 0.01, and ***P < 0.001.
Kang et al., Sci. Adv. 2020; 6 : eaay5413     26 February 2020
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
5 of 13
supported by complete linkage hierarchical clustering analysis, in which 
ADSCs cocultured with HUVECs exhibited more within-group 
similarities compared with the corresponding BMSC culture condi-
tions (fig. S3). ADSCs exhibited EC-like coformation with 2D 
HUVEC networks on the gel surface, whereas BMSCs demonstrated 
pericyte-like colocalization with HUVECs within the 3D inner 
matrix in 14 days, as observed by z-stack confocal imaging (Fig. 3B).
Analysis of paracrine secretion from the coculture groups further 
supports the above results. A recent study has reported that platelet- 
derived growth factor BB (PDGF-BB) promotes recruitment of 
pericytes to EC networks, resulting in enhanced vessel stabilization 
(18). The BMSC coculture on day 6 induces significantly more 
secretion of PDGF-BB compared with the ADSC coculture on day 14 
(Fig. 3C-i), whereas the HUVEC monoculture maintained the highest 
level of secretion among the groups for the entire culture period, as 
pericyte recruitment was continuously required. ANGPT1 stabilizes 
newly formed blood vessels and is largely produced by pericytes (19). 
BMSC coculture maintained its higher secretion compared with the 
other groups during the 14-day culture (Fig. 3C-ii). In contrast, 
VEGF, one of the most important growth and survival factors for 
endothelium, was released significantly more from the ADSC co-
culture compared with the other groups (Fig. 3C-iii). These results 
agree with recent reports that BMSCs behave like pericytes by wrap-
ping around HUVEC tubes for 83 days (20), whereas ADSCs act 
like ECs in promoting their angiogenic activities in a mouse model 
of hindlimb ischemia.
Next, we conducted a gene microarray analysis to determine the 
global-scale differences in phenotypic marker expression. First, fold 
Fig. 3. In vitro coculture of hMSCs with HUVECs in NO gel for 14 days. (A) Morphology of HUVECRFP in coculture with ADSCs or BMSCs (n = 3) on days 1, 7, and 14. 
(B) 2D network formation with ADSCs on the gel surface versus 3D close contact of BMSCs with HUVECRFP in coculture by z-stack confocal microscopy. Yellow color 
indicates overlap of green phalloidin (hMSC) and red RFP (HUVECRFP)) (t, top of gel; b, bottom of gel). (C) Secretion of proangiogenic factors (i) PDGF-BB, (ii) ANGPT1, 
and (iii) VEGF from HUVECs only and in their coculture with ADSCs or BMSCs (n = 3) (*P < 0.05, ***P < 0.001 for HUVECs only versus cocultures and #P < 0.05, ##P < 0.01, 
and ###P < 0.001 for ADSC-HUVEC versus BMSC-HUVEC). (D) Hierarchical clustering analysis from profiling expression of pericyte marker genes. Heat map analysis for 
comparison between groups from GeneChip Human Gene 2.0 ST Array results (n = 2) showing significant differences in the expression of ≥2-fold changes between BMSCs 
(B) and ADSCs (A) (B/A) or between HUVEC coculture with BMSCs (BH) and with ADSCs (AH) (BH/AH). A dendrogram of the cluster correlation is shown on the left. The 
colors indicate expression levels (red, increased; black, equal; green, decreased expression comparing B versus A or BH versus AH). (i) Increased (19 genes) and (ii) decreased 
expression (15 genes) in B versus A as opposed to BH versus AH is presented on the right. Confirmation of CYP1B1 (cytochrome P450 family 1 subfamily B member 1) 
and S1PR1 (sphingosine-1-phosphate receptor 1) expression by (E) real-time qPCR (fold changes of B to A or BH to AH) and by (F) immunostaining. All data are shown as 
means ± SD. *P < 0.05 and ***P < 0.001.
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changes were analyzed compared with HUVEC monoculture (table S2). 
Gene expressions of pericyte markers, endosialin and platelet-derived 
growth factor receptor beta (PDGFRβ), were markedly up-regulated in 
both coculture conditions, whereas expressions of other pericyte genes 
varied slightly higher or lower compared with the HUVEC monoculture. 
These results agree with previous reports that endosialin is preferentially 
expressed on mural cells, including pericyte, but not by ECs (21), and 
blocking the PDGF pathway leads to pericyte deficiency (22). We further 
analyzed both microarray and real-time quantitative polymerase chain 
reaction (qPCR) results by comparing BMSCs to ADSCs with (right 
column) or without (left column) HUVEC coculture (table S3). Among 
the eight genes compared by microarray or qPCR, the expressions of 
six genes were significantly higher in both columns, although there were 
large variations in their fold changes. These results suggest that the 
NO gel predominantly supports pericyte characteristics of BMSCs 
compared with ADSCs.
The microarray results exhibited clear differences in the NO- 
mediated expression of angiogenesis, pericyte, and migration-related 
genes among HUVECs, BMSC coculture, and ADSC coculture as 
well as between ADSCs and BMSCs both in monoculture or both in 
coculture (fig. S4). In particular, a hierarchical clustering analysis of 
830 pericyte markers was applied to the microarray results, and genes 
showing different expression patterns upon comparison of BMSCs 
with ADSCs with or without HUVEC coculture are presented 
(Fig. 3D). There are large differences in gene expression patterns 
between BMSCs and ADSCs both in monoculture, between BMSCs 
and ADSCs both in coculture with HUVECs, and between the mono- 
and coculture conditions. Because pericyte- or EC-like characteristics 
became more apparent in coculture with HUVECs in the NO gel, 
our next analysis focused on changes in gene expression from the 
monoculture to coculture conditions. Notably, the expression of 
cytochrome P450 family 1 subfamily B member 1 (CYP1B1) was higher 
(8.08-fold) in BMSCs compared with ADSCs in monoculture, but 
not in coculture (0.23-fold). This trend was reversed in sphingosine-
1- phosphate receptor 1 (S1PR1) expression, which was lower (0.24-fold) 
in BMSCs than in ADSCs in monoculture but increased significantly 
in coculture (27.85-fold). The results were confirmed by qPCR 
(Fig. 3E) and immunostaining (Fig. 3F). These results align with the 
previous study (23), which reported that BMSCs act like pericytes. 
CYP1B1 deficiency leads to proliferation, migration, and survival of 
pericytes, whereas S1PR1 is required for pericyte interaction with 
ECs; thus, S1PR1 knockout mice show blocked vascular maturation 
(24). Further analysis of microarray results by a volume plot of gene 
expression levels demonstrates that gene expression of connective 
tissue growth factor, an essential factor for pericyte adhesion during 
angiogenesis (25), was higher (22.63-fold change; volume, 10.59) in 
BMSCs compared with ADSCs in coculture (fig. S3) within the NO gels.
Ex vivo culture in NO gel
In ex vivo coculture with rat aortic rings, the patterns of CYP1B1 
expression were similar to the coculture results, as evidenced by its 
higher expression in BMSCs compared with ADSCs in monoculture 
(Fig. 4A). Its expression was maintained at high levels in both co-
culture conditions with aortic rings, suggesting that some degree of 
CYP1B1 expression is required to maintain both pericyte and EC 
functions (17), as supported by the fact that CYP1B1-deficient mice 
fail to elicit a neovascular EC response during oxygen-induced ischemic 
retinopathy (26). Expression of Flk1, a major EC marker, was not 
detected in the culture of only the aortic ring but was clearly observed 
in ADSC coculture with aortic rings (fig. S5A). In alignment with 
the coculture results, S1PR1 was more highly expressed in the BMSC 
coculture compared with the ADSC coculture (Fig. 4B). However, 
S1PR1 expression was not detected in MSCs alone, which is expected 
because S1PR1 expression is activated in the context of interaction 
between pericytes, as reported by recent studies.
Neural/glial antigen 2 (NG2) is consistently expressed by pericytes 
of developing vascular structures (27). NG2 was highly expressed in 
the monoculture of both hMSC types, and its expression increased 
more in the BMSC–aortic ring coculture compared with the ADSC 
coculture (Fig. 4C). The expression patterns were similar to those of 
PDGFR (Fig. 4D), and the human origin of BMSCs was confirmed 
(fig. S5B). PDGFR is a crucial regulatory factor for the prolifera-
tion, migration, and survival of pericytes (28).
In vivo wound healing assay
NO promotes wound healing through collagen deposition with cell 
migration and proliferation (29). Moreover, MSCs have shown 
beneficial effects on cutaneous wound healing and skin regeneration, 
in part because of pericyte functions (30), as well as promoting 
EC-mediated angiogenesis (31). Thus, a wound healing assay may 
further confirm the NO effect on the differences in hMSC source–
dependent proangiogenic mechanisms. In this in vivo model of wound 
healing, wound closure of BMSC-embedded NO gels was faster 
(Fig. 5A), as evidenced by earlier formation of collagen fibers with 
more delayed inflammatory infiltration in the wound areas compared 
with the other groups (Fig. 5B). The BMSC- and ADSC-embedded 
groups formed PECAM1+ neovascular networks at the wound sites 
with complete involucrin-positive epithelial healing compared with 
the other test groups (fig. S6). However, only the BMSC-embedded 
group showed distinct colocalization of -smooth muscle actin–
positive (SMA+) and PECAM1+ signals within the wound site, 
indicating the peracetic roles of BMSCs in enhancing vessel forma-
tion and maturation during wound healing. When the remaining 
area of the NO gel in the wound healing model was quantitatively 
determined by Masson’s trichrome (MT) staining with an image 
analysis (yellow dot areas in Fig. 5B-i with Fig. 5B-iii), the remaining 
gel area significantly decreased from the NO gel–only group to the 
ADSC + NO gel group and further to the BMSC + NO gel group, 
whereas hNuclei+ cells were enriched in the tissue areas where the 
test gels were located and degraded, supporting the pericyte- or EC 
function–dependent differences in the healing speed (Fig. 5C-ii) and 
associated gel degradation (Fig. 5C-iii).
Pericyte characteristics were determined by quantitative analysis 
and visualization of pericyte markers (CD146, NG2, and desmin) and 
human nuclei expression (Fig. 5C). Significantly more cells stained 
positive for both the pericyte marker and the human nuclei marker 
in the BMSC group than in the ADSC group (Fig. 5C-i), which was 
confirmed by immunostaining (Fig. 5C-ii). The results further support 
the pericyte-like behavior of BMSCs to accelerate wound healing.
In vivo gel plug assay
A gel plug angiogenesis assay was conducted to determine whether 
NO promotes a causative role of EC-like behavior of ADSCs in in-
ducing vasculogenesis in this context. After 14 days, more distinct 
vessel structures were observed in the ADSC-embedded NO gel 
group compared with the other groups (Fig. 6A). Blood perfusion, 
an indication of functional vessel formation, was confirmed in the 
ADSC and BMSC groups by injecting fluorescent beads into the left 
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ventricle of a mouse heart (Fig. 6B). The ADSC group showed higher 
fluorescence intensity compared with the other groups. The MT 
staining results showed that more cells migrated to the gel surface of 
the ADSC group compared with the other groups (Fig. 6C). More-
over, the Flk1+ vessel density increased in the ADSC group compared 
with the other groups (Fig. 6D). These results suggest that the NO 
gel promoted EC-like characteristics of ADSCs, thereby inducing 
neovascularization more effectively compared with the BMSCs in the 
gel plug assay in vivo, although BMSCs are able to induce vessel 
formation to some degree.
DISCUSSION
Because NO promotes various EC functions (32), inhibition of NO 
bioactivity usually reduces angiogenesis, as evidenced by the anti-NO 
effect of oxidized LDL inhibiting capillary sprouting from segments 
of rabbit thoracic aorta or human coronary artery (33). Our results 
also agreed with the fact that NO inhibition by AG treatment sig-
nificantly reduced tubulogenesis of hMSCs in the NO gel. Because 
the beneficial effects of NO on angiogenesis and hMSC behavior have 
been widely studied but in different ways, this NO gel served as the 
first platform to elucidate hMSC source–dependent angiogenic 
mechanisms, representing a critical value in the field of biomaterials 
and regenerative medicine. This in-depth study could not be carried 
out without this NO gel setting to program continuous release of 
NO by depositing a source in the matrix. This advanced functional 
material platform is expected to address the long-standing issue of 
the temporal release of most delivery settings in the field.
The NO hydrogel system with stiffness optimization (1.5-kPa 
elastic modulus) allowed for the easy placement of cells in a 3D 
environment in addition to the NO release, followed by the investi-
gation of progressive changes in hMSC behaviors from the 3D inner 
matrix to the 2D gel surface. First, in monoculture, both types of stem 
cells showed NO-mediated in vitro angiogenic activities, as evidenced 
by tube formation and proangiogenic molecule expression, which was 
enhanced when the passage was increased from 3 (early) to 6 (late). 
When both hMSCs were compared, BMSCs produced more ANGPT1, 
a pericyte-driven vessel stabilization factor, whereas ADSCs produced 
more PECAM1 and Flk1, which are EC-driven proangiogenic fac-
tors, indicating that the NO gel promoted dominant pericyte- and 
EC-like properties of BMSCs and ADSCs, respectively, in this con-
text. These different characteristics became more evident when these 
cells were cocultured with HUVECs because (i) vessel stabilization 
was superior in coculture with BMSCs; (ii) BMSCs were localized in 
contact with ECs, whereas ADSCs moved to the gel surface by 
forming an EC-like 2D layer; and (iii) the ELISA, gene microarray, 
and PCR results demonstrated that more pericyte markers were 
produced in BMSCs with HUVECs compared with ADSCs with 
HUVECs. The pericyte-like BMSC and EC-like ADSC activities were 
confirmed by an ex vivo assay in aortic ring coculture with hMSCs 
and in in vivo wound healing and gel plug assays.
Pericytes communicate with ECs via both direct physical contact 
and paracrine signaling, thereby regulating vascular stability and 
homeostasis (34). MSCs and pericytes have phenotypic similarities 
with functional equivalence (12). In this study, the promotive 
effects of NO gel on the pericyte-like characteristics of BMSCs were 
Fig. 4. Ex vivo coculture of rat aortic ring and hMSC NO gel culture. Immunostaining analysis of pericyte markers (A) CYPB1, (B) S1PR1, (C) NG2, and (D) PDGFR ana-
lyzed by (i) merged z-stack confocal image, (ii) ortho visualization, and (iii) 3D image. NG2 expression was visualized at the (vi) near and (v) far sides from the aortic ring 
(t, top of NO gel; b, bottom of NO gel).
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demonstrated via a series of results. It is worthwhile to evaluate the 
expression of CYP1B1 and S1PR1. CYP1B1 expression was higher 
in BMSCs compared with that in ADSCs but decreased the most 
among others in coculture with HUVECs or aortic rings (Figs. 3, D to F, 
and 4A). These results indicate that CYP1B1 function was deactivated 
when BMSCs interacted with HUVECs and suggests a pericyte-like 
role of BMSCs, which is supported by a recent study (23) that 
showed that CYP1B1 deficiency leads to proliferation, migration, 
and survival of pericytes. In contrast, S1PR1 expression was lower 
in BMSCs than in ADSCs, but its expression increased significantly 
more in BMSC-HUVEC coculture compared with the ADSC-HUVEC 
coculture. S1PR1 binds to sphingosine-1-phosphate (S1P), which 
plays a key role in the communication between ECs and pericytes 
(24). Thus, the higher S1PR1 expression in the BMSC coculture with 
the aortic ring compared with the ADSC-ring coculture (Fig. 4D) 
clearly supports the predominant pericyte mechanism of BMSCs 
for angiogenesis through NO functions. Moreover, when the marker 
expression was compared between the MSC monoculture and the 
HUVEC coculture for the 2-week period (table S3), PDGFR, an 
early pericyte marker (35), was expressed more in the BMSC mono-
culture compared with the ADSC monoculture as opposed to the 
results from the HUVEC coculture conditions. In contrast, the 
expression of SMA, a late pericyte marker (36), was higher in the 
BMSC-HUVEC coculture compared with the ADSC-HUVEC co-
culture as opposed to the monoculture conditions. These results 
indicate that compared with ADSCs, more mature pericyte charac-
teristics of BMSCs were developed in coculture with HUVECs, although 
the expression of an early, immature pericyte marker was dominant 
in the corresponding monoculture conditions.
A previous study reported that pericyte-like MSC function acceler-
ated wound healing by promoting angiogenesis, anti-inflammatory 
activities, and more organized dermis/epidermis formation (37). 
Our wound healing study also demonstrated that when implanted 
with the NO gel, the higher BMSC number with colocalized expression 
of pericyte markers (NG2 and CD146) and human nuclei resulted 
in accelerated wound healing compared with the ADSC group. In 
contrast, the absence of MSCs in the aortic ring assay resulted in the 
promotion of microvessel outgrowth in the NO gel 2.4% (#1) com-
pared to the other test gel types, and the implantation of the same 
NO gel type with ADSCs accelerated perfusable vessel growth even 
more with dominant expression of EC markers in the gel plug assay. 
These results support the overarching suggestion that NO mediates 
Fig. 5. In vivo wound healing study with hMSCs embedded in NO gels for 14 days. (A) Representative macroscopic images of wound closure sites among the test 
groups (photo credit: Mi-Lan Kang, Yonsei University College of Medicine). (B) (i) MT staining (sc, stratum corneum; sg, stratum granulosum; ss, stratum spinosum) with 
quantitative analysis of (ii) the defect length from the calculation of the length of nonregenerated stratum granulosum (between red arrows on each group) and (iii) the 
remaining gel areas (yellow dotted lines in the right panel of MT staining images) as an indication of in vivo gel degradation. (C) (i) Quantitative analysis of cell numbers 
positive for both pericyte markers (CD146, NG2, or desmin) and hNuclei. (ii) Immunostaining images of pericyte markers and hNuclei. Yellow arrows indicate cells double 
stained with pericyte marker+ and hNuclei+. All data are shown as means ± SD. *P < 0.05 and ***P < 0.001.
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the pericyte mechanism of BMSCs and promotes the EC-like properties 
of ADSCs in the gel implantation status. With respect to the NO gel 
degradation and hNuclei+ cell population in the wound healing assay 
(Fig. 5B), a clear conclusion cannot be made regarding whether 
hNuclei+ cells migrated from or just remained around the gel areas 
under the effect of NO release. However, it is most likely that hNuclei+ 
cells contributed to the tissue regeneration in some variation depend-
ing on the pericyte and EC functions, considering the differences of 
the remaining gel areas among the test groups.
In the current study, it was not possible to determine the effects 
of sex and age differences of the donors of the two MSC types 
because BMSCs were exclusively extracted from old patients who 
were subject to hip replacement surgery because of avascular necrosis 
of the femoral head (AVNFH) (38). In contrast, ADSCs were exclu-
sively extracted from young female patients who underwent liposuction 
(39). However, MSCs underwent a robust quality control process 
regarding the inherent MSC morphology and phenotype markers 
to ensure minimal differences in the healthy status of the two MSC 
types before the experiments. A future study is proposed to investigate 
these variables after setting up reliable clinical sources in collabora-
tion with a hospital. In this way, more novel insights into the regu-
latory roles of NO in MSC type–specific angiogenic mechanisms will 
be provided in alignment with this current study. In particular, 
although it has been almost impossible to obtain BMSCs from young 
donors, this advanced setting of clinical source will inform the importance 
of (i) NO signaling, (ii) the mechanism-dependent selection of the 
MSC type, and (iii) the effects of donor age and sex in therapy for 
old patients with AVNFH.
METHODS
Cells and experimental animals
BMSCs were isolated from bone marrow aspirates of patients with 
AVNFH with a mean age of 77 years (range, 64 to 90 years; n = 4) 
who underwent total hip replacement surgeries. ADSCs were isolated 
from four patients with a mean age of 39.5 years (range, 38 to 42 years; 
n = 4) who underwent liposuction. Informed consent was obtained 
from all donors. The isolation and use of these cells were approved 
by the Institutional Review Board (IRB) of Dongguk University Ilsan 
Hospital (IRB no. 2012-34) and Yonsei University College of Medicine 
(IRB no. 4-2016-1111). During culture, adherent cells were selected 
from a plastic culture plate surface, and their phenotypes were con-
firmed by flow cytometry using hMSC phenotyping kits (Miltenyi 
Biotech, Germany, and BD Biosciences, USA) according to the manu-
facturers’ instructions. Dulbecco’s modified Eagle’s medium (DMEM)–
low glucose (Gibco) with fetal bovine serum (10%, v/v; Gibco) and 
an antibiotic-antimycotic solution (1%, v/v; Gibco) was used for 
culture. The degree of population doubling as a function of passaging 
up to 10 was calculated by determining the difference between 
the numbers of harvested and plated cells at each passage using the 
Fig. 6. In vivo gel plug study with hMSCs in NO gels. (A) Subcutaneous implantation of test groups with plug formation (left panel with white arrows) under the dorsal 
skin of nude mice, followed by harvest of test groups after 14 days (right) (photo credit: Mi-Lan Kang, Yonsei University College of Medicine). (B) 3D visualization of 
perfusable vessel formation by injecting fluorescence beads through the left ventricle of the heart by z-stack confocal microscopy. (C) MT and (D) Flk1 staining of the 
harvested samples.
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following formula: [log10(N) − log10(N0)]/log10(2). The population 
doubling time was determined using the formula (t − t0)∙log2/
log(N − N0), where t − t0 is the culture time (in hours), N is the 
number of harvested cells, and N0 is the number of cells at the be-
ginning point. HUVECs were purchased from the American Type 
Culture Collection (ATCC; USA), and their authentication is available 
in ATCC. The experimental animals were 8-week-old male Sprague- 
Dawley rats (Orient Inc.) and 6-week-old male BALB/c nude mice 
(Orient Inc.). All animal experiments were performed in accordance 
with the Korean Food and Drug Administration guidelines. Protocols 
were approved by the Institutional Animal Care and Use Committee of 
the Yonsei Laboratory Animal Research Center (permit no. 2016-0194).
Hydrogel fabrication and rheological analysis
TI transglutaminase formula (mTG; Modernist Pantry) was dissolved 
in phosphate-buffered saline (PBS) (mTG weight/total solution volume: 
w/v%) at NO gels 2.43% (#1), 4.76% (#2), and 9.6% (#3), followed 
by addition of gelatin (Sigma-Aldrich) at 5.5% (w/v) in PBS. The ratio 
of mTG to gelatin was consistently 9:1 (v:v). Elastic modulus, an indi-
cation of gel stiffness, was measured using a rheometer (MCR 102; 
Anton-Paar) at 37°C by determining the storage modulus (G′) and 
loss modulus (G″) in a frequency sweep mode at a frequency range 
from 0.1 to 10 Hz under constant 1% shear strain.
Ammonia assay
NO gels 2.4% (#1), 4.8% (#2), and 9.6% (#3) were formed by mTG- 
mediated cross-linking of gelatin. Media supernatants were then 
collected to determine ammonia concentrations during the cross- 
linking reaction of test gels (n = 3). Samples were centrifuged for 5 min 
at 14,000 rpm to remove particles. The ammonia concentration was 
measured using an ammonia assay kit (Sigma-Aldrich) following the 
manufacturer’s instructions. Briefly, samples were mixed and reacted 
with working reagents for 15 min in the dark at room temperature. 
The fluorescence intensity as an indication of total ammonia con-
centration was measured at Ex = 360 nm and Em = 450 nm (BioTek, 
Republic of Korea).
Polyamine assay
ADSCs (1 × 106 cells/ml; n = 2 in triplicates) at P6 were mixed with 
NO gels (2.4% #1, 4.8% #2, and 9.6% #3) and cultured for 5 days, 
which were then collected and chopped in 100 l of cold PBS using 
a homogenizer to extract the intracellular polyamines, followed by 
centrifugation at 14,000 rpm for 20 min at 4°C. The supernatants 
were collected and subjected to the assay in accordance with the 
manufacturer’s instruction (BioVision, USA). Briefly, polyamine 
developer mix and diluted polyamine probe were added to the samples, 
which were incubated for 30 min at room temperature. The absorbance 
of each sample as an indication of polyamine concentration was mea-
sured at 570 nm using a colorimetric microplate reader (BioTek).
hMSC culture in NO gel
BMSCs or ADSCs (1 × 106 cells/ml; n = 4) at P3 were mixed with the 
gel solutions at varying mTG concentrations, and then, the mixed 
solution underwent gelation by mTG-mediated cross-linking of 
gelatin. The gel size was 60.8 mm3 for in vitro culture in 24-well 
plates. Cell viability was determined using a LIVE/DEAD Viability/
Cytotoxicity Kit (Invitrogen) following the manufacturer’s instructions. 
Briefly, cells were incubated in media containing 4 mM calcein-AM 
and 2 mM ethidium homodimer-1 for 1 hour, and then, nuclei were 
counterstained with 4′,6-diamidino-2-phenylindole (DAPI; Sigma- 
Aldrich). Live (green) and dead (red) cells with nuclei (blue) were 
imaged by confocal microscopy (LSM780; Zeiss, Oberkochen).
Ex vivo aortic ring culture assay
A rat thoracic aorta was harvested and rapidly dissected into 1-mm-
thick rings in PBS with penicillin-streptomycin (1%, v/v; Gibco), 
followed by removing the surrounding fat and perivascular tissues 
and washing out the blood in PBS. A sliced ring was then embedded 
in an NO gel and maintained at 37°C with 5% CO2 in EC growth 
medium-2 (EGM-2) (Lonza) for 10 days. To determine the inde-
pendent effect of NO versus gel stiffness, the NO concentration 
among the three test gels was equalized with varying the stiffness. 
NO gels of 2.4% (#1) and 4.8% (#2) were supplemented with 0.191 
and 0.1035 mM ammonia, respectively, to reach the level equal to 
9.6% (#3). Areas of neovessel outgrowth from the aortic rings (n = 10) 
were quantitatively analyzed using ImageJ software [National Insti-
tutes of Health (NIH)]. Then, the incremental multiple of vascular 
sprouting area from 7 to 10 days was determined and presented as a 
ratio with the value corresponding to the NO gel 9.6% (#3) set to 1.
In vitro angiogenic activities of hMSCs in NO gel
P3 or P6 of ADSCs or BMSCs (1 × 106 cells/ml; n = 4) was encapsu-
lated in the NO gel 2.4% (#1) and cultured for 14 days in the absence 
of any proangiogenic growth factors. The same number of cells was 
propagated on TCPS, a 2D culture control. Cell morphology with 
sprouting and tube formation was visualized by LSM780 confocal 
microscopy (Zeiss) after LIVE/DEAD and DAPI staining, as described 
above. The expression of cell markers at the gene and protein levels 
was determined by PCR, qPCR, immunocytochemistry, Western 
blotting, and ELISA. The uptake of LDL by hMSCs (n = 2) was de-
termined on day 14 after culture in NO gels. Cells were washed with 
PBS and incubated in an assay buffer containing fluorophore-labeled 
LDL (0.2 mg/ml) (BioVision, USA) at 37°C for 24 hours, followed 
by quantitative analysis of the internalized LDL amount into cells 
using the assay kit, according to the manufacturer’s instruction 
(BioVision, USA). The functional assay results were compared with 
those of TCPS (negative control) and HUVECs (positive control) 
using the same protocols.
PCR and qPCR
Total RNA was extracted from cells by TRIzol extraction reagent 
(Invitrogen) following the manufacturer’s instructions (n = 4). 
Expression levels of numerous genes were determined by PCR and 
qPCR. Angiogenesis-related genes included CD34, PECAM1, Flk1, 
and VE-cadherin. Stemness-related genes included c-Myc, Klf4, and 
CD271. NO biosynthesis–associated genes included intercellular 
adhesion molecule 1 (ICAM1), interleukin-6 (IL-6), clusterin (CLU), 
pentraxin-related protein 3 (PTX3), and prostaglandin-I synthase 
(PTGIS). Complementary DNA (cDNA) was synthesized using the 
AccuPower CycleScript RT PreMix (Bioneer) according to the 
manufacturer’s instructions. PCR was performed on a T100 Thermal 
Cycler (Bio-Rad) using a HiPi Plus 5× PCR premix (Elpisbio), and 
the products were analyzed by 2% (w/v) agarose gel electrophoresis. 
Real-time qPCR was performed on a StepOnePlus Real-Time PCR 
System (Applied Biosystems) using SYBR Green PCR mix (Thermo 
Fisher Scientific). Each gene expression was normalized to 40S ribosomal 
protein S18 (RPS18) and analyzed by the relative quantification 
2−Ct method. The values were further normalized to the corresponding 
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samples in the TCPS culture and are presented as fold changes. 
Primer sequences are listed in table S4.
NO assay
The NO assay was carried out using a colorimetric kit (Abcam) after 
a 5-day culture of ADSCs or BMSCs at P6 (1 × 106 cells/ml) in NO 
gel 2.4% (#1) (n = 3). The same number of cells was propagated on 
TCPS as a 2D culture control. Samples were collected and chopped 
in a cold assay buffer (100 l) to extract nitrate and nitrite, followed 
by centrifugation at 14,000 rpm for 20 min at 4°C for collection of 
supernatants. Culture media were also collected on days 5 and 14 to 
measure the secreted NO concentration and then mixed with the 
supernatants to determine the total NO amount of each sample from 
the intracellular fraction and in the media. The cumulative NO 
release from gels into the culture media was profiled by collecting 
culture media without gels, followed by determining the NO con-
centration over the course of time points. The absence (NO gel only) 
versus presence of hMSCs was compared. The subsequent procedures 
of NO assay were conducted in accordance with the manufacturer’s 
instructions (Abcam). Briefly, deproteinized cells were reacted with 
nitrate reductase and enzyme cofactor for 1 hour at room tempera-
ture. After treating with Griess reagent, nitrate changed to a purple 
azo compound. The level of azo compound as an indication of the 
NO amount was measured using a colorimetric microplate reader 
at 540 nm (BioTek).
Immunocytochemistry
Samples (n = 3) were fixed with 4% paraformaldehyde (Sigma-Aldrich), 
permeabilized with 0.3% Triton X-100 (Sigma-Aldrich) in PBS, and 
blocked with 5% bovine serum albumin (Millipore). Samples were 
incubated with primary goat anti-PECAM1 (1:100; Santa Cruz Bio-
technology) and rabbit anti-Flk1 (1:100; Santa Cruz Biotechnology) 
antibodies, followed by washing and incubating with secondary 
anti-goat conjugated to Alexa Fluor 488 (1:200; Invitrogen) and 
anti-rabbit conjugated to Alexa Fluor 488 (1:200; Invitrogen) anti-
bodies with or without Alexa Fluor 594 Phalloidin (1:500; Invitrogen) 
for cytoskeleton staining. Nuclei were counterstained with NucBlue 
Live ReadyProbes Reagent (Invitrogen). Images were obtained using 
an LSM780 confocal laser scanning microscopy.
NO inhibition test
ADSCs or BMSCs at P6 (106 cells/ml; n = 3) were encapsulated in 
NO gel 2.4% (#1) and cultured for 5 or 14 days with or without AG 
(1 mM), a NO inhibitor. The cytoskeletons were visualized by 
immunofluorescence after staining with Alexa Fluor 488 phalloidin 
(1:200; Invitrogen), followed by imaging with an LSM780 confocal 
laser scanning microscope. Subsequently, angiogenic parameters 
including node, junction, segment, and total length were quantita-
tively analyzed using Image J (see http://image.bio.methods.free.fr/
ImageJ for the manual).
Western blotting
Total proteins were isolated from samples by lysing with radio-
immunoprecipitation assay buffer (Sigma-Aldrich), and protein 
concentrations were determined using a Bradford assay (Sigma- 
Aldrich). Protein extracts were run on a 10% (w/v) SDS–polyacrylamide 
gel electrophoresis gel and then electrotransferred onto a nitro-
cellulose membrane. The membranes were blocked in TBST [20 mM 
tris, 0.9% NaCl, and 0.1% Tween 20 (pH 7.4)] with 5% (w/v) skim 
milk and then incubated with primary rabbit anti-CD31 (PECAM1) 
(1:100; Abcam, Cambridge), rabbit anti-Flk1 (1:100; Santa Cruz 
Biotechnology), and rabbit anti–-tubulin (1:100; Abcam) antibodies, 
followed by treatment of secondary goat anti-rabbit immunoglobulin 
G (IgG) (H + L) horseradish peroxidase (HRP)–conjugated (1:2000; 
Vector Labs) antibodies. The signals were visualized using the ECL 
Plus Western Blotting Detection Kit (Amersham Biosciences) accord-
ing to the manufacturer’s instruction and analyzed using an image 
reader LAS-3000 (Fujifilm, Tokyo). This experiment was performed 
in triplicate with a mix of three different donor samples (n = 3).
Enzyme-linked immunosorbent assay
Secretion levels of ANGPT1 protein in sample supernatants were 
determined using ELISA kits (PeproTech) according to the manu-
facturer’s instructions. Briefly, standards and sample supernatants 
were added into predefined wells and incubated for 2 hours at room 
temperature. After the plates were washed with washing buffer, avidin 
HRP conjugates were added to the plates at room temperature for 
30 min, followed by washing and addition of ABTS liquid substrate 
solution to each well. The absorbance of each well was measured at 
405 nm with wavelength correction setting at 650 nm. Cumulative 
amounts of ANGPT1 secretion were calculated on the basis of a 
standard curve (n = 3).
HUVEC coculture in NO gel
P6 BMSCs or P6 ADSCs (n = 3) were precultured in NO gels for 
1 day, and 5 × 105 cells/ml of RFP-HUVECs (HUVECRFP; PromoCell) 
were seeded on the gel surface layer and cultured in EGM-2 
for 14 days. HUVECRFP morphologies with sprouting and network 
formation during tubulogenesis were visualized by LSM780 con-
focal microscopy on days 1, 7, and 14. HUVECRFP monoculture 
served as a control. Distribution and migration of hMSCs in co-
culture with HUVECs from 3D inside to the NO gel surface were 
monitored by cytoskeletal staining using Alexa Fluor 488 phalloidin 
(1:500; Invitrogen) with LSM780 confocal imaging. The protein se-
cretion levels of PDGF-BB, VEGF, and ANGPT1 in the sample 
supernatants were determined by ELISA (n = 3), as described in the 
above section.
Gene microarray
Microarray assays were conducted to profile the global scale of gene 
expression. GeneChip Human Gene 2.0 ST Array containing more 
than 24,000 probes (Affymetrix) was used, and the results were 
analyzed using the Affymetrix GeneChip Command Console 
Software. Triplicate samples for each group were pooled together, 
and microarrays were conducted in duplicate. Genes showing 
greater than twofold differences in expression between test groups 
were selected, and then, GeneSpring Software 7.2 (QIAGEN) was 
used for hierarchical clustering analysis and dendrogram visual-
ization to determine complete linkage and Pearson correlation. 
Annotation of selected genes was performed using the DAVID 
Bioinformatics Resources (https://david.ncifcrf.gov) and the 
Stanford Online Universal Resource for Clones and Expressed 
sequence tags (http://source-search.princeton.edu). Angiogenesis-, 
pericyte-, and migration-related genes were analyzed and cate-
gorized using Core Analysis in Ingenuity Pathways Analysis 5.5 
(Ingenuity Systems). To validate the microarray results, real-time 
qPCR and immunocytochemistry were conducted, as described in 
the above section.
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Ex vivo coculture with rat aortic ring in NO gel
Rat aortic rings were prepared using the same method as in the 
above section. Aortic rings were embedded in NO gels with hMSCs 
(106 cells/ml; n = 2) and maintained at 37°C and 5% CO2 in EGM-2 
for 14 days. Expressions of pericyte-related markers including 
CYP1B1, S1PR1, NG2, and PDGFR were evaluated by immuno-
cytochemistry as described above. Expression of angiogenesis-related 
markers was additionally evaluated by immunostaining using primary 
rabbit anti-Flk1 antibody (1:100; Santa Cruz Biotechnology) with 
secondary biotinylated goat anti-rabbit IgG (Vector Labs) antibodies. 
To visualize aortic rings, Cy5-conjugated streptavidin (Vector Labs) 
was treated with fluorescein isothiocyanate–conjugated lectin 
(Sigma-Aldrich). To determine cells of human origin, human 
mitochondria were stained with primary anti-human mitochondria 
antibodies (1:20; Millipore). Z-stack or single-plane images were 
obtained using an LSM780 confocal microscope (Zeiss), and the images 
were analyzed using ZEN imaging software (ZEN 2012; Zeiss).
In vivo wound healing assay
The dorsal surface of 6-week-old male BALB/c nude mice was dis-
sected, followed by removing the epidermis, dermis, and subcutaneous 
tissue to obtain full-thickness wounds with a consistent square shape 
(~18-mm length for each of the four equal sides with a gel size of 
324 mm3). The mice were randomly divided into five groups (n = 6 
per group): normal, sham, NO gel only (hMSC-free control), ADSC- 
embedded NO gel, and BMSC-embedded NO gel. P6 BMSCs or P6 
ADSCs (n = 2) were embedded in NO gels at a final concentration 
of 106 cells/ml and cultured for 1 day at 37°C and 5% CO2 in DMEM 
(Gibco) and then transplanted into wounds. Wound areas with trans-
planted gels were protected by covering with sterilized Tegaderm 
films (3M Health Care) and maintained for 14 days.
Analysis of wound model
On day 14 after wound implantation, each scar tissue was harvested 
with a rim of healthy normal tissue, fixed in 10% buffered formalin, 
and embedded in paraffin. Paraffin blocks were dissected to 4-m-
thick slices and stained with MT staining using a ready-to-use kit 
(Sigma-Aldrich). Briefly, after deparaffinization and hydration, the 
sample slices were immersed in Bouin’s solution, followed by staining 
with Weigert’s hematoxylin and Biebrich scarlet acid fuchsin. The 
samples were then incubated with phosphotungstic-phosphomolybdic 
acid solution and stained with aniline blue solution, followed by in-
cubation in acetic acid solution. To determine the degrees of wound 
closure, the length of nonregenerated stratum granulosum was cal-
culated in the MT images. In vivo degradation of NO gels was determined 
by calculating the remaining gel area in the MT staining images using 
ImageJ software (NIH).
Protein expression of pericyte-related markers was evaluated by 
immunostaining with primary rabbit anti-CD146 (1:200; Abcam), 
rabbit anti-NG2 (1:100; Abcam), and rabbit anti-desmin (1:100; Abcam) 
antibodies overnight at 4°C after deparaffinization and hydration. 
Samples were incubated with mouse anti-human nuclei (1:20; 
Millipore) antibodies, with subsequent overnight incubation with 
biotinylated goat anti-rabbit IgG (Vector Labs) antibodies at 4°C, 
followed by incubation with Cy5-conjugated streptavidin (Vector Labs) 
with anti-mouse IgG conjugated to Alexa Fluor 488 (Invitrogen) for 
1 hour at room temperature to confirm the human source of hMSCs. 
Anti-PECAM1 (1:100; Santa Cruz Biotechnology) and anti-SMA 
(1:100; Abcam) antibodies were additionally used to visualize neo-
vascularization and pericyte locations in wound sites. Epithelium 
formation, an indication of complete healing, was evaluated by staining 
the stratum corneum and granulosum with anti-involucrin antibodies 
(1:200; Abcam). All samples were counterstained with DAPI and 
mounted with VECTASHIELD mounting medium (Vector Labs). 
Images were obtained at six randomly selected sites on each slide by 
LSM780 confocal microscopy with quantitative analysis of the number 
of marker positive cells among the total number of cells.
In vivo gel plug assay
NO gel solution (200 l) with P6 hMSCs (106 cells/ml; n = 2) or 
without cells (hMSC-free control) was injected into two subcutaneous 
sites (right and left symmetrically) of 6-week-old male BALB/c nude 
mice and maintained for 3 weeks. To visualize perfusable vessel for-
mation in the plug sites, mice were perfused with a heparinized 
fluorescent microbead solution (Thermo Fisher Scientific). Briefly, 
heparinized saline (10 IU/ml) was injected into the left ventricle 
after amputating the internal vena cava, followed by perfusion of 
heparinized fluorescent microbead solution in saline. Gel plugs were 
then harvested and subjected to LSM780 confocal imaging. The 
paraffin sections were obtained from the plug parts and stained with 
MT, as previously described in the above sections. To confirm neo-
vascularization into gel plugs, tissue section slices were stained with 
primary rabbit anti-Flk1 antibody (Santa Cruz Biotechnology) and 
secondary phycoerythrin (PE)–conjugated goat anti-Rabbit IgG (Thermo 
Fisher Scientific) antibody, followed by LSM780 confocal imaging.
Statistical analysis
Descriptive statistics were used to determine the group means and 
SDs. Statistical comparisons were analyzed using (i) two-way analysis 
of variance (ANOVA) with Bonferroni’s post hoc analysis for more 
than two groups with more than one factor or (ii) one-way ANOVA for 
more than two groups with one factor (SPSS 15.0; SPSS Inc.). P values 
are presented in each figure and its legend.
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